RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval

RNS-60 is under clinical development by Revalesio and currently in Phase II for Acute Ischemic Stroke.

Cantourage Group SE launches a range of high-THC medicinal cannabis flowers in Switzerland together with Astrasana – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Market Launch Cantourage Group SE launches a range of high-THC medicinal cannabis flowers in Switzerland together with Astrasana

October 25, 2023

Natural antioxidants could delay age-related decline in male testosterone production

Natural polyphenolic compounds to enhance testosterone production and prevent age-related hypogonadism in aging males.

June 12, 2024

Ceftriaxone Prevents Ventilator-Associated Pneumonia After Brain Injury

PHOENIX — Administering ceftriaxone prophylactically in the intensive care unit (ICU) reduced the risk of ventilator-associated pneumonia (VAP) among patients with an acute brain injury,

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.